🇺🇸

US SEC Filing Intelligence

· daily

High-Value Federal Grants ($5M+) — August 06, 2026

This digest covers $755.6 million in high-value federal grants and contracts, all civilian (0% defense), with an average signal strength of 4.0/10, indicating limited actionable investment insight. The dominant award is a $506.5 million Department of Education delivery order to Pennsylvania Higher Education Assistance Agency (PHEAA) for student loan servicing, but PHEAA is a state government entity, not a publicly traded company, offering no direct equity exposure. A $128.1 million HHS contract to NDChealth Corporation for IT services provides a moderate materiality signal (8/10) but lacks key details on pricing and competition. A $121.1 million expired DHS contract with Leidos, Inc. (2006-2010) offers no forward-looking relevance. The highest-conviction signal is the neutral-to-weak data quality, with no bullish or bearish signals identified. Key risk: the lack of defense contracts and the expired nature of the Leidos award limit sector-specific investment catalysts.

3 total filings
· daily

General Federal Contracts — August 06, 2026

The three contracts analyzed total $755.6 million in obligations, all from civilian agencies (0% defense), signaling a period of low defense-sector contract activity. The dominant theme is stable, recurring civilian IT and financial services spending, with the Department of Education's $506.5 million award to PHEAA for loan servicing representing the highest-conviction signal—though it offers no direct equity opportunity as the recipient is a state agency. The $128.1 million contract to NDCHEALTH CORPORATION from HHS provides a potential growth signal for health IT services, but lacks detail for high confidence. A key risk is the expired nature of the $121.1 million Leidos DHS contract, which offers no current competitive insight. Overall, the digest reveals limited actionable investment signals due to the civilian focus and lack of publicly traded prime contractors with clear competitive moats.

3 total filings
· daily

S&P 500 Technology Sector SEC Filings — August 06, 2026

The 19 filings from the S&P 500 Technology sector reveal a bifurcated landscape: high-growth cloud software companies like Datadog are delivering exceptional revenue expansion (36% YoY) and investing aggressively in AI, while mature hardware firms like KLA and Lam Research show stable but less dynamic performance. Insider activity is a key theme, with significant selling by top executives at CrowdStrike, Microsoft, and Datadog, partially under 10b5-1 plans but still warranting caution. Accenture's broad insider awards suggest retention focus rather than conviction. Capital allocation trends are mixed, with Datadog pursuing M&A (Adaptive ML) while others like Analog Devices show routine insider sales. The sector is heavily focused on AI infrastructure, with Datadog's acquisition and KLA's high materiality filing pointing to semiconductor and observability demand. Overall, the data suggests strong growth in cloud/AI segments but potential overvaluation risks, as insiders monetize gains.

15 high priority 4 medium 19 total filings
· daily

Nasdaq 100 Stocks SEC Filings — August 06, 2026

The August 6, 2026 filing batch for the NASDAQ-100 reveals a clear pattern of insider profit-taking across mega-cap tech and growth names, with CEOs and directors at Microsoft, Netflix, CoreWeave, and Booking Holdings executing significant sales, often under 10b5-1 plans. This wave of insider selling, totaling over $14M in disclosed transactions, suggests management is capitalizing on elevated valuations, particularly in the AI and cloud infrastructure space. While Fidelity's routine 13G filings for Meta and Netflix confirm passive institutional ownership, the insider activity signals potential near-term caution. The Gilead 10-Q and Amazon 13F-HR lack enriched data, limiting their contribution, but the aggregate insider selling pattern is the dominant theme, warranting close monitoring for further distribution.

21 high priority 6 medium 27 total filings
· daily

US Activist Hedge Fund Institutional SEC 13D 13G — August 06, 2026

This digest of 50 SEC filings reveals a broad pattern of passive institutional ownership adjustments as of June 30, 2026, with FMR LLC (Fidelity) and FIL Limited being the most active filers. Key themes include significant stake reductions in SPACs by W.R. Berkley, a notable position decrease by FMR in Scorpio Tankers, and continued large passive stakes in companies like Ceribell (15.0%), Bruker Corp (15.0%), and Cardinal Infrastructure (14.9%). The data shows a clear rotation away from blank-check companies and selective trimming in energy and shipping, while maintaining or increasing positions in healthcare, technology, and infrastructure. The absence of activist filings (all 13G) suggests a period of stability, but the scale of Fidelity's holdings (multiple 5%+ stakes) provides a strong institutional floor for several names. No forward-looking guidance or insider trading activity was present in the enriched data, limiting catalyst-based insights.

4 high priority 46 medium 50 total filings
· daily

S&P 500 Financials Sector SEC Filings — August 06, 2026

The 16 filings from S&P 500 Financials companies reveal a sector in transition, with major banks and insurers reporting mixed Q2 2026 results. A clear theme is insider selling at the highest levels, particularly at Goldman Sachs and Mastercard, where the CEO and other top executives sold significant stock, signaling potential caution. While core earnings at JPMorgan, Citigroup, and BlackRock appear stable, the lack of detailed forward guidance in many filings creates uncertainty. The Morgan Stanley Direct Lending Fund shows a slight NAV decline despite higher net investment income, highlighting valuation pressure in private credit. Passive institutional ownership remains a stabilizing force, as seen in BlackRock's and Fidelity's routine 13G filings for MetLife and Northern Trust. Overall, the sector shows resilience in earnings but faces headwinds from insider sentiment and a lack of clear growth catalysts, warranting a selective approach.

11 high priority 5 medium 16 total filings
· daily

S&P 500 Energy Sector SEC Filings — August 06, 2026

The USA S&P 500 Energy sector filings for August 6, 2026 reveal a sector in transition: while earnings surged dramatically—led by Chevron's 385% YoY net income jump and ConocoPhillips' near-doubling of net income—production volumes are under pressure. ConocoPhillips reported a 6% decline in total production year-over-year, even excluding dispositions, signaling that higher prices rather than operational growth are driving record profits. Targa Resources posted a solid 21.5% net income rise driven by midstream fee growth, but capital spending surged 79% on acquisitions. The sector is increasingly bifurcated between 'capital-return machines' like ConocoPhillips, which doubled share repurchases to $2B, and 'growth-by-acquisition' plays like Targa Resources, which completed a $1.3B deal. Forward-looking actions are notable: ConocoPhillips is re-entering Syria and acquiring a 42% stake in a Kirkuk JV, adding geopolitical risk. Insider activity is minimal but significant—Texas Pacific's 10% owner made a token purchase. Overall, the sector shows strong cash flow momentum, massive shareholder returns, but declining organic production and rising geopolitical risk, creating a complex picture for investors.

5 high priority 2 medium 7 total filings
· daily

S&P 500 Consumer Staples Sector SEC Filings — August 06, 2026

The S&P 500 Consumer Staples filings this week reveal a bifurcated sector: traditional core players (Molson Coors, Estée Lauder) face demand headwinds and margin compression, while financial heavyweights signal conviction through passive holdings (Fidelity in Target). Insider selling is the dominant theme—notably a massive $14.9M CEO sell-down at Colgate-Palmolive and a director sale at Church & Dwight following a large option exercise—suggesting insiders are cashing out near perceived peaks. Molson Coors’ Q2 miss (sales -3.3% YoY, net income -46%) with reaffirmed guidance points to a defensive outlook but stable cash generation (cash +56% QoQ to $2.1B), while Estée Lauder’s 5.8% passive reduction by Fidelity signals institutional caution on luxury beauty. Period-over-period trends across filings show a clear pattern of cost inflation (Molson Coors COGS +6% YoY, MG&A +3.7%) eroding margins, even as gross dollar values hold. The portfolio-level takeaway: investors should expect continued margin squeeze in beverage and personal care, with insider selling providing a clear warning on valuation, while deep-value opportunities may emerge from forced sell-offs or turnarounds tied to premiumization (Coors Banquet, Peroni).

4 high priority 3 medium 7 total filings
· daily

US Material Events SEC 8-K Filings — August 06, 2026

The August 6, 2026, filing cycle reveals a market dominated by significant M&A and capital markets activity, particularly in the healthcare and energy sectors. Key period-over-period trends show a mixed picture: while First Advantage reported record revenues (+14.9% YoY) and raised guidance, Vital Farms experienced a sharp revenue decline (-10.1% YoY) and swung to a loss, highlighting sector-specific pressures. The most critical developments include Tarsus Pharmaceuticals' $450M acquisition of Alkeus, backed by a $125M oversubscribed PIPE, and the transformative merger of Sunrise Realty Trust and Southern Realty Trust, creating a $534M CRE lender. Portfolio-level patterns indicate a strong preference for debt financing (Quanta Services, Karman Holdings) and strategic M&A funded by equity (Tarsus, Ensysce Biosciences), while governance changes are widespread but often lack detail. The overall sentiment is cautiously optimistic, with several high-conviction bullish signals tempered by notable risk flags, including a financial restatement at CreditRiskMonitor and a CEO departure at ProFrac.

50 high priority 50 total filings
· daily

Insider Trading Pulse — August 06, 2026

Today's insider trading digest reveals a market characterized by routine equity compensation awards and a handful of high-conviction insider purchases, balanced against notable sales by executives and a major 10% owner. The most significant cluster of activity is at Eos Energy Enterprises, where the CEO and multiple directors exercised options and warrants, signaling confidence in the company's future despite the dilutive nature of the transactions. Conversely, a large sell-off by a 10% owner in Anteris Technologies and a CEO's disposal of ADS in Weibo Corp raise cautionary flags. Positive signals emerge from open-market purchases by the Presidents of Toyota Motor and Bed Bath & Beyond, as well as the CEO of Tiziana Life Sciences, suggesting management sees value at current levels. A recurring theme is the use of 10b5-1 plans for sales, which provides a layer of pre-planned context. The data also shows a significant volume of option grants at Kamada Ltd, indicating a broad-based incentive strategy for its board. Overall, the sentiment is mixed, with a slight tilt toward neutral as many transactions are pre-scheduled or compensatory in nature.

50 high priority 50 total filings
· daily

Dow Jones 30 Stocks SEC Filings — August 06, 2026

The August 6, 2026 batch of Dow 30 filings reveals a stark divergence between the energy and financial sectors. Chevron's Q2 2026 earnings surged 385% YoY to $12.07B, driven by a 51% revenue jump and robust cash flow generation, while the company aggressively returned $11.5B to shareholders via dividends and buybacks. In contrast, insider selling at Goldman Sachs, 3M, and Microsoft signals potential caution among senior executives, with Microsoft's Commercial CEO alone selling $4.88M in stock. JPMorgan Chase's 10-Q (materiality 6/10) and the 13F-HR filings from Johnson & Johnson, Amazon, and Visa Foundation provide additional portfolio and venture investment context, though the latter three are lower materiality. The overall theme is one of strong operational performance at Chevron offset by notable insider profit-taking at several blue-chip names, suggesting a mixed near-term outlook for the index.

4 high priority 4 medium 8 total filings
· daily

US Corporate Distress Financial Stress SEC Filings — August 06, 2026

The two filings in this corporate distress digest both involve Nasdaq non-compliance issues, highlighting a common theme of small-cap companies struggling with exchange listing requirements. Olenox Industries (formerly Safe & Green Holdings) resolved its periodic filing delinquency, receiving a positive confirmation from Nasdaq after filing overdue 10-K and 10-Q reports, signaling a potential turnaround. In contrast, Accuray Inc. was forced to transfer its listing to the Nasdaq Capital Market due to a persistent bid price deficiency below $1.00, receiving a 180-day extension to February 2027 to regain compliance. While Olenox's resolution removes an immediate overhang, Accuray's situation remains precarious with no near-term catalyst for price recovery. The absence of enriched period-over-period data, insider activity, or forward-looking guidance in both filings limits quantitative trend analysis, but the qualitative distress signals are clear: one company is emerging from delinquency, while the other faces ongoing price-based delisting risk.

2 high priority 2 total filings
· daily

Global High-Priority Regulatory Events — August 06, 2026

This digest covers 50 filings from August 6, 2026, dominated by critical market events including insolvencies, tender offers, and M&A activity. A key theme is the surge in corporate insolvency actions in India, with Sun Granite Export Ltd and Value Industries Ltd entering or continuing CIRP, signaling distress in the Indian industrial sector. The quantum computing SPAC merger between Bleichroeder Acquisition Corp. II and Pasqal reached a key milestone with SEC effectiveness, but carries significant governance and tax risks for shareholders. The healthcare sector saw a major acquisition with argenx's $77/share tender offer for Forte Biosciences, while Ensysce Biosciences executed a complex acquisition of Cy Biopharma with a $77 million financing package. Tender offer activity was mixed, with Apollo Debt Solutions BDC seeing strong demand (oversubscribed 3.36x), while several funds like Privacore PCAAM and AB Private Lending saw zero participation. Liberty Global's €1 billion acquisition of VodafoneZiggo closed, marking a major European telecom consolidation. Period-over-period data reveals a sharp 51% revenue decline at Morepen RX Limited and a 14.6% revenue drop at Jetking Infotrain Ltd, contrasting with 9.3% revenue growth at HCG Rajkot and strong advertising revenue growth at TIM Goa Airport Advertising (up 27% YoY).

50 high priority 50 total filings
· daily

S&P 500 Consumer Discretionary Sector SEC Filings — August 06, 2026

The six filings in the Consumer Discretionary stream reveal a sector bifurcated between cautious insider behavior and strategic capital deployment. Insider activity is mixed: a significant $5M director purchase at Aptiv signals confidence in the auto-tech supplier, while pre-planned sales at Booking and Starbucks are routine and not alarming. Hilton's tax-related share withholding is neutral. Amazon's 13F and eBay's 10-Q, though lacking detailed enriched data, indicate ongoing portfolio management and operational stability. Key themes include a focus on capital returns (buybacks, dividends) and the use of 10b5-1 plans for orderly insider transactions. The absence of major guidance changes or operational red flags suggests a stable, mature sector, with the most actionable signal being Aptiv's insider buying.

5 high priority 1 medium 6 total filings
· daily

S&P 500 Healthcare Sector SEC Filings — August 06, 2026

The 25 filings reveal a bifurcated healthcare landscape: animal health leader Zoetis faces persistent demand headwinds and cut FY2026 guidance, while diversified giants like Danaher and BD signal confidence through substantial insider equity awards. Insider selling at Pfizer and Cigna, though modest in size, contrasts with heavy insider accumulation at Danaher, suggesting divergent management conviction. Fidelity's increased stakes in Moderna (13.1%) and Biogen (12.4%) highlight institutional conviction in large-cap biotech, while J&J's venture portfolio shows strategic bets in early-stage therapeutics. Capital allocation trends show aggressive buybacks at Zoetis (up 48% YoY) despite earnings decline, and Danaher's equity awards point to long-term incentive alignment. Key catalysts include Zoetis's guidance revision and upcoming earnings calls, while BD's results remain opaque pending further disclosure.

17 high priority 8 medium 25 total filings
· daily

US Earnings Financial Results SEC Filings — August 06, 2026

The 50 filings for the period ending August 6, 2026, reveal a market with divergent performance, where strong revenue growth and margin expansion in select consumer and energy sectors contrast with significant balance sheet strain and rising debt levels in capital-intensive industries. A clear theme is the aggressive use of leverage for M&A and buybacks, with Constellation Energy's debt surging 175% post-Calpine acquisition and Planet Fitness borrowing to fund share repurchases, while banks like Bancorp and OFG face deposit outflows and are turning to short-term borrowings. Period-over-period comparisons highlight a bifurcation: Halozyme and Bob's Discount Furniture show robust double-digit revenue and profit growth, while Viasat and Alliance Resource Partners report revenue declines and widening losses. Insider activity is sparse, but capital allocation decisions—particularly the surge in share buybacks at Halozyme and Planet Fitness—signal management confidence, though at the cost of balance sheet strength. Forward-looking data is limited, but scheduled events and debt maturities (e.g., Viasat's $661.9M current debt) create near-term catalysts. The overall picture is one of selective strength, with opportunities in high-growth, cash-generating companies and risks in over-levered, asset-heavy firms.

50 high priority 50 total filings
· daily

US Executive Compensation Proxy SEC Filings — August 06, 2026

This set of 10 proxy filings reveals a market bifurcated between routine governance and transformative, high-conviction corporate actions. While six filings are low-materiality procedural matters (election of directors, auditor ratification), four filings describe pivotal events—mergers, reverse stock splits, and reincorporations—that carry material valuation and governance implications for shareholders. A dominant theme is the aggressive pursuit of public listing compliance at any cost: Sky Quarry (SKYQ) seeks a second reverse split (up to 1:625 aggregate) to maintain Nasdaq listing, while Healthy Choice Wellness (HCWC) is pursuing a transformational merger with Host Digital to move from wellness to data centers, accepting fixed merger consideration and no appraisal rights. The Bleichroeder-Pasqal combination introduces significant governance risk by reincorporating in France, reducing SEC oversight, and potentially weakening board independence. The only insider activity signal in the entire batch—a late Form 3 filing by a portfolio manager at First Trust High Yield Opportunities 2027 Term Fund (FTHY)—is a compliance break rather than conviction. Overall, the highest-conviction opportunities lie in shorting the pre-merger stocks of HCWC and SKYQ, given the forced nature of their restructuring and the dilution shareholders face. The majority of filings lack financial data for period-over-period comparisons, limiting systematic trend analysis but highlighting a sector-wide governance fatigue in smaller caps and SPACs.

10 high priority 10 total filings
· daily

US IPO Pipeline SEC S-1 Filings — August 06, 2026

Today's IPO pipeline filings present a mixed landscape of opportunity and risk. Alternus Clean Energy and Rainier Acquisition Corp have filed S-1s, but both lack critical financial data, making immediate assessment impossible. In contrast, Jones Soda Co.'s filing is highly material, revealing a strategic pivot away from its cannabis-infused business due to new federal THC caps, while retaining its hemp-derived beverage line. The overarching theme is regulatory uncertainty in the beverage sector, with Jones Soda's restructuring creating a clear catalyst. Investors should focus on the upcoming SEC review for all three, but particularly watch for Jones Soda's financials and the outcome of its licensing deal.

3 high priority 3 total filings
· daily

US SEC Trading Suspension Halt Orders — August 06, 2026

The two filings in this USA Trading Suspensions digest highlight contrasting outcomes for Nasdaq-listed companies facing regulatory non-compliance. Olenox Industries (formerly Safe & Green Holdings) successfully resolved a periodic filing delinquency, regaining compliance and avoiding a suspension, which is a positive signal for its continued listing. In contrast, Accuray Inc. was forced to transfer its listing to the Nasdaq Capital Market due to a persistent bid price deficiency, a clear negative event that signals financial distress. The key period-over-period trend is the divergence in resolution paths: one company cured its deficiency through administrative action (filing reports), while the other required a structural change (market tier transfer). The most critical development is Accuray's transfer, which, while not a delisting, carries a stigma and may trigger further selling pressure. The portfolio-level pattern is that regulatory compliance issues, whether from filing lapses or price declines, are being actively managed by companies but with very different implications for shareholder value.

2 high priority 2 total filings
· daily

US Executive Officer Management Changes SEC — August 06, 2026

The August 6, 2026 batch of 39 filings reveals a high volume of officer changes, but with a notable lack of detail in many cases, creating uncertainty. Key themes include a mix of planned successions (e.g., Arteris, STAAR Surgical) and unexplained departures (e.g., authID, Ultra Clean Holdings, ProFrac Holding Corp). Financial performance is mixed: First Advantage reported record revenues and raised guidance, while Mastech Digital saw a YoY revenue decline but strength in its Data & AI segment. A significant special dividend from CommScope (Vistance Networks) highlights a major capital return event. The most critical development is the CEO change at ProFrac Holding Corp, where the founder takes over amid improving but still loss-making operations. Overall, the stream points to a market with active leadership churn, where investors must differentiate between routine transitions and potential red flags.

39 high priority 39 total filings